StockNews.com began coverage on shares of RiceBran Technologies (NASDAQ:RIBT – Get Rating) in a report published on Saturday morning. The firm issued a sell rating on the stock.

RiceBran Technologies Stock Up 3.3 %

RiceBran Technologies stock opened at $0.31 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.06 and a current ratio of 1.29. The business's 50-day simple moving average is $0.57 and its two-hundred day simple moving average is $0.48. The company has a market cap of $16.22 million, a PE ratio of -1.41 and a beta of 0.45. RiceBran Technologies has a fifty-two week low of $0.27 and a fifty-two week high of $1.03.

RiceBran Technologies (NASDAQ:RIBT – Get Rating) last posted its quarterly earnings results on Thursday, April 28th. The company reported ($0.03) earnings per share for the quarter. RiceBran Technologies had a negative net margin of 33.42% and a negative return on equity of 36.82%. The firm had revenue of $10.56 million for the quarter.

Insider Transactions at RiceBran Technologies

Institutional Trading of RiceBran Technologies

A number of hedge funds have recently modified their holdings of the stock. State Street Corp acquired a new position in RiceBran Technologies in the 1st quarter worth about $69,000. FNY Investment Advisers LLC acquired a new position in RiceBran Technologies in the 2nd quarter worth about $71,000. Finally, Arnhold LLC raised its holdings in RiceBran Technologies by 23.1% in the 1st quarter. Arnhold LLC now owns 240,000 shares of the company's stock worth $108,000 after purchasing an additional 45,000 shares during the period. Hedge funds and other institutional investors own 28.60% of the company's stock.

About RiceBran Technologies

(Get Rating)

RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company. It focuses on producing, processing, and marketing of value-added healthy, natural, and nutrient dense products derived from rice and other small grains. The company converts raw rice bran into stabilized rice bran (SRB) and high value derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious carbohydrate and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends.

Featured Stories

• Get a free copy of the StockNews.com research report on RiceBran Technologies (RIBT)
• MarketBeat: Week in Review 7/25 – 7/29
• Procter's Earnings Start To Show Weakness In Q4
• The One Question You Have to Ask Before Investing in INTC Stock
• Home Depot: A Beautiful Boring Stock to Navigate a Bear Market
• Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?

Receive News & Ratings for RiceBran Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RiceBran Technologies and related companies with MarketBeat.com's FREE daily email newsletter.